Summary

The global protein and protein crystals market is projected to reach USD 960.37 billion by 2030 from USD 609.51 billion in 2025, at a CAGR of 9.5% from 2025 to 2030.

https://mnmimg.marketsandmarkets.com/Images/proteins-protein-crystals-market-img-overview.webp

The protein and protein crystals market is primarily driven by the growing demand for biopharmaceuticals, increasing R&D in structural biology and drug discovery, and the rising use of proteins in diagnostics, therapeutics, and industrial applications. Enzymatic proteins lead the market due to their wide use in therapeutics, industrial biocatalysis, and high-throughput screening, while recombinant and monoclonal proteins drive demand in drug development and personalized medicine because of their specificity and scalability.
Additionally, the growing adoption of protein crystallization kits, reagents, and automated crystallization platforms for structural studies further fuels the market, as researchers and pharmaceutical companies increasingly rely on these products to determine protein structures, accelerate drug design, and enhance enzyme-based industrial processes.

By product type, the structural proteins segment is expected to register the highest CAGR during the forecast period.

By product type, the structural proteins segment is expected to account for the highest CAGR in the protein and protein crystals market. The growth of the structural proteins segment in the protein and protein crystals market is driven by multiple factors across research, healthcare, and industrial applications. Research proteins such as actin and tubulin are in high demand for structural biology, high-throughput crystallography, and drug discovery, enabling precise protein structure determination and rational drug design. Membrane proteins are increasingly sought after as critical therapeutic targets in the development of biologics and precision medicine. Connective tissue and extracellular matrix proteins, including collagen, elastin, laminins, and proteoglycans, are fueling demand in biomaterials, tissue engineering, and regenerative medicine, as well as in cosmetic and healthcare products.

By application, the healthcare segment accounted for the highest CAGR of the market in 2024.

The healthcare application segment is expected to register the highest CAGR in the proteins and protein crystals market due to the increasing demand for therapeutic proteins, monoclonal antibodies, vaccines, and diagnostic enzymes. Growing prevalence of chronic diseases, cancer, and metabolic disorders is driving the development and use of protein-based biologics, while advances in structural biology and protein crystallography are accelerating drug discovery and targeted therapy. Rising investments in biopharmaceutical R&D, clinical research, and high-throughput protein analysis are fueling the adoption of protein crystals and related products in healthcare, making this segment the fastest-growing compared with industrial, food, and research applications. as therapeutic and structural proteins are increasingly being used in biologics development. The rising incidence of hereditary and chronic diseases is driving the need for protein-based treatments. Precise structure-based drug design is made possible by developments in protein crystallography, which drives biopharmaceutical innovation. Expanding clinical applications and higher R&D expenditures also contribute to this market's growth.


Asia Pacific is expected to register the highest growth rate in the market during the forecast period.

The Asia-Pacific region is expected to register the highest CAGR in the protein and protein crystals market due to strong growth across healthcare, research, and other applications. In healthcare, increasing biopharmaceutical R&D, rising prevalence of chronic diseases, and adoption of personalized medicine are driving demand for therapeutic proteins, monoclonal antibodies, and protein-based diagnostics. In research and academia, expanding life sciences infrastructure, CROs, and structural biology initiatives boost the use of protein crystallization kits and reagents. Other applications are contributing to market growth, in agriculture and animal health, proteins and enzymes are used for feed additives, vaccines, and disease management; in cosmetics, structural proteins like collagen and elastin are applied in anti-aging and skincare products; and in bioenergy, enzymes facilitate biomass conversion and biofuel production. The combined demand across healthcare, research, agriculture, animal health, cosmetics, and bioenergy is fueling rapid market growth in Asia-Pacific.

A breakdown of the primary participants referred to for this report is provided below:
? By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
? By Designation: C-level Executives (55%), Directors (27%), and Others (18%)
By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), and the Middle East & Africa (2%)

The prominent players in this market are Danaher (US), Thermo Fischer Scientific inc. (US), Sanofi (France), Agilent (US), Takeda Pharmaceutical Company (Japan), International Flavours and Fragrances (US), Biocon (India), RayBiotech (US), Merck KGaA (Germany), Amgen (US), Eli lilly (US), Roche (Switzerland), Novo Nordisk (Denmark), and Pfizer (US), among others.


Research Coverage

The protein and protein crystals market is segmented by product type, application, end user, and region. Key factors influencing market growth include driving forces, restraints, opportunities, and challenges for stakeholders. The report also reviews the leading companies competing in the Protein and Pprotein Ccrystals market. A micro-level analysis can be conducted to examine trends, growth opportunities, and contributions to the market. Additionally, it highlights potential revenue growth opportunities across various market segments in five major regions.

Key Benefits of Buying the Report

The report is valuable for new entrants in the protein and protein crystals market as it provides comprehensive information about the market. This information is essential for understanding various investment opportunities. The report provides insights into both key and smaller players in the market, which can help create a solid basis for risk analysis when making investment decisions. It accurately segments the market by end users and regions, providing focused insights into specific market segments. Additionally, the report highlights key trends, challenges, growth drivers, and opportunities to support strategic decision-making through a thorough analysis.






The report provides insights into the following points:
? Key drivers (Rising demand for therapeutic proteins, Advancements in protein crystallization and structural biology, increasing applications in food processing and industrial biotechnology), restraints (High production and purification costs, Limited stability and storage of protein-based products), opportunities (Emergence of AI and automation in protein crystallography, Integration of hybrid and 3D printing technologies, Collaborations between academia and industry), and challenges (reproducibility issues in protein crystallization, Competition from alternative analytical techniques)
? Product Development/Innovation: Emerging technologies in space, R&D, recent product launches & approvals in the protein and protein crystals market.
? Market Growth: In-depth insights into remunerative markets report analyze the protein and protein crystals market across varied geographies.
? Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the protein and protein crystals market
? Competitive Assessment: Detailed assessment of market share, service offerings, leading strategies of major players such as Danaher (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La F. Hoffmann-La Roche AG (Switzerland), Roche Ltd (Germany), Amgen (US) and Merck KGaA (Germany), among others..

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 30
1.3.2 INCLUSIONS & EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 31
1.3.4 CURRENCY CONSIDERED 32
1.4 STAKEHOLDERS 32
2 EXECUTIVE SUMMARY 33
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 33
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 34
2.3 DISRUPTIVE TRENDS IN PROTEINS & PROTEIN CRYSTALS MARKET 35
2.4 HIGH-GROWTH SEGMENTS 36
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 37
3 PREMIUM INSIGHTS 38
3.1 PROTEINS & PROTEIN CRYSTALS MARKET OVERVIEW 38
3.2 VALUE CHAIN ANALYSIS OF PROTEINS & PROTEIN CRYSTALS MARKET 39
3.3 NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION AND END USER, 2025 40
3.4 GEOGRAPHIC SNAPSHOT OF PROTEINS & PROTEIN CRYSTALS MARKET 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 42
4.2 MARKET DYNAMICS 42
4.2.1 DRIVERS 43
4.2.1.1 Increasing emphasis on structure?based drug discovery and development 43
4.2.1.2 Rising demand for protein-based drug development 43
4.2.1.3 Increasing demand for therapeutic proteins 44
4.2.1.4 Technological advancements in crystallization methods 44
4.2.2 RESTRAINTS 45
4.2.2.1 High technical complexity and low success rates in protein crystallization 45
4.2.2.2 Exposure to ionizing radiation and contrast-related concerns among vulnerable populations 46
4.2.2.3 Need for high costs, technical expertise, and advanced infrastructure for commercialization 46
4.2.3 OPPORTUNITIES 47
4.2.3.1 Integration of AI-enabled innovations 47
4.2.3.2 Collaboration between academia and industry 47
4.2.3.3 High investment and funding in structural biology, biopharmaceuticals, and advanced drug development 48
4.2.4 CHALLENGES 49
4.2.4.1 Reproducibility issues in protein crystallization 49
4.2.4.2 Scalability concerns in recombinant protein production 49
4.3 UNMET NEEDS 50
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 50
4.5 STRATEGIC MOVES BY TIER1/2/3 PLAYERS 50
5 INDUSTRY TRENDS 51
5.1 PORTER’S FIVE FORCES ANALYSIS 51
5.1.1 BARGAINING POWER OF BUYERS 52
5.1.2 BARGAINING POWER OF SUPPLIERS 52
5.1.3 THREAT OF NEW ENTRANTS 52
5.1.4 THREAT OF SUBSTITUTES 52
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 52
5.2 MACROECONOMIC OUTLOOK 53
5.2.1 GDP TRENDS & FORECAST 53
5.2.2 TRENDS IN GLOBAL ENVIRONMENTAL INDUSTRY 53
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 54
5.3 SUPPLY CHAIN ANALYSIS 54
5.3.1 PROMINENT COMPANIES 54
5.3.2 SMALL & MEDIUM-SIZED ENTERPRISES 54
5.3.3 END USERS 55
5.4 VALUE CHAIN ANALYSIS 55
5.4.1 RESEARCH & DEVELOPMENT 55
5.4.2 MANUFACTURING 55
5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 55
5.5 ECOSYSTEM ANALYSIS 56
5.6 PRICING ANALYSIS 57
5.6.1 AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY PRODUCT, 2024 58
5.6.2 AVERAGE SELLING PRICE TREND OF PROTEINS & PROTEIN CRYSTALS, BY REGION, 2022?2024 58
5.7 TRADE ANALYSIS 60
5.7.1 IMPORT DATA FOR HS CODE 3507, 2021?2024 61
5.7.2 EXPORT DATA FOR HS CODE 3507, 2021?2024 62
5.7.3 TRADE ANALYSIS FOR HS CODE 293719 63
5.8 KEY CONFERENCES & EVENTS, 2025?2026 65
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 66
5.10 INVESTMENT & FUNDING SCENARIO 66
5.11 CASE STUDY ANALYSIS 68
5.11.1 COMPUTATIONAL DESIGN OF HIGH-AFFINITY MINIBINDER PROTEINS FOR THERAPEUTIC TARGETS 68
5.12 IMPACT OF 2025 US TARIFF ON PROTEINS & PROTEIN CRYSTALS MARKET 68
5.12.1 KEY TARIFF RATES 69
5.12.2 KEY TARIFF RATES 69
5.12.3 PRICE IMPACT ANALYSIS 69
5.12.4 IMPACT ON COUNTRY/REGION 70
5.12.4.1 North America 70
5.12.4.1.1 US 70
5.12.4.2 Europe 70
5.12.4.3 Asia Pacific 70
5.12.5 IMPACT ON END-USE INDUSTRIES 70
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS 71
6.1 KEY EMERGING TECHNOLOGIES 71
6.1.1 CRYO-CRYSTALLIZATION 71
6.1.2 X-RAY FREE-ELECTRON LASERS (XFELS) 71
6.1.3 COMPUTATIONAL PROTEIN DESIGN TOOLS 71
6.2 COMPLEMENTARY TECHNOLOGIES 71
6.2.1 MICROFLUIDICS AND LAB-ON-A-CHIP (LOC) TECHNOLOGIES 71
6.2.2 NUCLEAR MAGNETIC RESONANCE (NMR) SPECTROSCOPY 72
6.3 PATENT ANALYSIS 72
6.4 IMPACT OF AI/GEN AI ON PROTEINS & PROTEIN CRYSTALS MARKET 73
6.4.1 TOP USE CASES AND MARKET POTENTIAL 73
6.4.2 BEST PRACTICES IN PROTEINS & PROTEIN CRYSTALS MARKET 73
6.4.3 CASE STUDIES 73
6.4.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 74
6.4.5 CLIENT’S READINESS TO ADOPT GEN AI IN PROTEINS & PROTEIN CRYSTALS MARKET 75
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 75
6.6 REGULATORY LANDSCAPE 76
6.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
6.7 INDUSTRY STANDARDS 81
6.8 CERTIFICATIONS, LABELLING, AND ECO-STANDARDS 81
6.8.1 CERTIFICATIONS & GOOD MANUFACTURING/QUALITY STANDARDS 81
6.8.2 LABELLING & TRACEABILITY 82
6.8.3 ECO-STANDARDS/ENVIRONMENTAL/SUSTAINABILITY CERTIFICATION 82
?
6.9 CUSTOMER LANDSCAPE & BUYER BEHAVIOUR 82
6.9.1 DECISION-MAKING PROCESS 82
6.10 KEY STAKEHOLDERS & BUYING CRITERIA 82
6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 82
6.10.2 KEY BUYING CRITERIA 83
6.11 ADOPTION BARRIERS AND INTERNAL CHALLENGES 85
6.12 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 85
7 PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE 86
7.1 INTRODUCTION 87
7.2 ENZYMATIC PROTEINS 87
7.2.1 INDUSTRIAL ENZYMES 88
7.2.1.1 Focus on green manufacturing and sustainable solutions to aid adoption 88
7.2.2 FOOD ENZYMES 89
7.2.2.1 Expansion of food-based technologies to propel market growth 89
7.3 THERAPEUTIC PROTEINS 90
7.3.1 MONOCLONAL ANTIBODIES 92
7.3.1.1 Advancing disease targeting and treatment through monoclonal antibody technologies to spur adoption 92
7.3.2 INSULIN 93
7.3.2.1 Strengthening investment scenario for insulin development to fuel market growth 93
7.3.3 HORMONES 94
7.3.3.1 Introduction of new drugs and therapies for hormonal diseases to propel segment growth 94
7.3.4 COAGULATION FACTORS 95
7.3.4.1 Enhanced hemostasis therapies through advanced coagulation protein technologies to augment market growth 95
7.4 STRUCTURAL PROTEINS 96
7.4.1 RESEARCH PROTEINS 97
7.4.1.1 Research proteins to empower drug discovery and molecular research with AI integration 97
7.4.2 STRUCTURAL PROTEINS 98
7.4.2.1 Advancements in structural protein through collagen and connective tissue insights to fuel market growth 98
7.5 SPECIALTY PROTEINS 99
7.5.1 INDUSTRIAL PROTEINS 100
7.5.1.1 Industrial proteins to optimize industrial processes through advanced protein technologies 100
7.5.2 NUTRITIONAL PROTEINS 101
7.5.2.1 Nutritional proteins to enable evidence-based, disease-specific nutrition for complementing pharmaceutical therapies 101
7.5.3 ANALYTICAL PROTEINS 102
7.5.3.1 Analytical proteins to support quality control and scientific discovery 102
7.5.4 COSMECEUTICAL PROTEINS 102
7.5.4.1 Focus on innovative personal care products to support segment growth 102
7.5.5 FUNTIONAL FOOD PROTEINS 103
7.5.5.1 Functional foods & beverages with advanced proteins to improve digestibility of nutritional profile 103
8 PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION 105
8.1 INTRODUCTION 106
8.2 HEALTHCARE 107
8.2.1 ADVANCEMENTS IN PROTEIN ENGINEERING, STRUCTURAL BIOLOGY, AND HIGH-THROUGHPUT CRYSTALLIZATION TO SPUR MARKET 107
8.3 TISSUE ENGINEERING 108
8.3.1 DEVELOPMENT OF ADVANCED REGENERATIVE MEDICINE THROUGH PROTEIN-BASED TISSUE ENGINEERING TO AID MARKET GROWTH 108
8.4 AGRICULTURE & ANIMAL NUTRITION 109
8.4.1 FOCUS ON BETTER AGRICULTURAL PRODUCTIVITY AND ANIMAL HEALTH THROUGH PROTEIN-BASED SOLUTIONS TO DRIVE MARKET 109
8.5 INDUSTRIAL PROCESSING 110
8.5.1 GROWING DEMAND FOR HIGH-PERFORMANCE AND ECO-FRIENDLY PRODUCTS TO DRIVE MARKET GROWTH 110
8.6 BIOENERGY & ENVIRONMENTAL 111
8.6.1 GROWING DEMAND FOR SUSTAINABLE ENERGY AND ECO-FRIENDLY SOLUTIONS TO BOOST MARKET GROWTH 111
8.7 COMECEUTICALS & NUTRACEUTICALS 112
8.7.1 ADVANCEMENTS IN PROTEIN-BASED NUTRACEUTICALS TO ENHANCE DIGESTIBILITY AND NUTRIENT DELIVERY 112
8.8 OTHER APPLICATIONS 113
9 PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER 114
9.1 INTRODUCTION 115
9.2 PHARMA INDUSTRY 115
9.2.1 DRUG DEVELOPMENT 116
9.2.1.1 Increased internal biologics discovery and process-development activity to augment market growth 116
9.2.2 FORMULATION/MANUFACTURING 117
9.2.2.1 Advancing protein therapeutics through optimized formulation and manufacturing to propel segment growth 117
9.2.3 STORAGE/INVENTORY MANAGEMENT 118
9.2.3.1 Optimal storage/inventory management to optimize supply, reduce waste, and prevent stockouts 118
9.3 BIOTECHNOLOGY INDUSTRY 119
9.3.1 DRUG DEVELOPMENT 120
9.3.1.1 Growth of precision/personalized medicines and advanced therapeutics to aid segment growth 120
?
9.3.2 FORMULATION/MANUFACTURING 121
9.3.2.1 Expansion of manufacturing facilities in biotechnology industry leading to support market growth 121
9.3.3 STORAGE/INVENTORY MANAGEMENT 122
9.3.3.1 Optimizing storage and inventory management for proteins and protein crystals to enhance safety, quality, and accessibility 122
9.4 RESEARCH, ACADEMIA, AND CROS 123
9.4.1 DRUG DEVELOPMENT & DISCOVERY 124
9.4.1.1 Focus on accelerating advancements protein & protein crystal applications to fuel segment growth 124
9.4.2 LIFE SCIENCE RESEARCH 125
9.4.2.1 Expanding scope of research for formulating targeted treatment strategies to boost Market 125
9.5 FOOD & BEVERAGE INDUSTRY 126
9.5.1 INCREASING DEMAND FOR HIGH PROTEIN DIETS, NUTRITIONAL SUPPLEMENTS, AND FUNCTIONAL FOODS TO AID MARKET GROWTH 126
9.6 OTHER END USERS 127
10 PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION 128
10.1 INTRODUCTION 129
10.2 NORTH AMERICA 129
10.2.1 US 133
10.2.1.1 US to dominate North American proteins & protein crystals market during study period 133
10.2.2 CANADA 136
10.2.2.1 Innovations in protein AI to drive advanced protein design and structure prediction 136
10.3 EUROPE 138
10.3.1 GERMANY 141
10.3.1.1 Favorable healthcare policies and regulatory landscape to drive market 141
10.3.2 UK 144
10.3.2.1 Favorable regulatory scenario for protein & protein crystal development to support market growth 144
10.3.3 FRANCE 146
10.3.3.1 Increased healthcare funding by government bodies to aid market growth 146
10.3.4 ITALY 149
10.3.4.1 Increased availability of reimbursement coverage for proteins and protein crystals to augment market growth 149
10.3.5 SPAIN 151
10.3.5.1 Ongoing research linking crystallography to disease mechanisms and infrastructure development to aid market growth 151
10.3.6 REST OF EUROPE 153
?
10.4 ASIA PACIFIC 155
10.4.1 CHINA 159
10.4.1.1 Emphasis on modernization and expansion of healthcare infrastructure to drive market 159
10.4.2 JAPAN 162
10.4.2.1 Rise in research applications using proteins & protein crystals to propel market growth 162
10.4.3 INDIA 164
10.4.3.1 Investments and funding activities in Indian biotechnology and biopharma industry to augment market growth 164
10.4.4 AUSTRALIA 167
10.4.4.1 Rising investments in healthcare infrastructure to drive market 167
10.4.5 SOUTH KOREA 169
10.4.5.1 Strong academic & research infrastructure and favorable national funding programs to aid market growth 169
10.4.6 REST OF ASIA PACIFIC 171
10.5 LATIN AMERICA 173
10.5.1 BRAZIL 177
10.5.1.1 Growing adoption of proteins in research centers and workshops to propel market growth 177
10.5.2 MEXICO 179
10.5.2.1 Increasing investments and funding for development and manufacturing of protein-based APIs to drive market 179
10.5.3 REST OF LATIN AMERICA 182
10.6 MIDDLE EAST & AFRICA 184
10.6.1 GCC COUNTRIES 187
10.6.1.1 Government initiatives for better digital health and improved telemedicine to drive market 187
10.6.2 REST OF MIDDLE EAST & AFRICA 190
11 COMPETITIVE LANDSCAPE 192
11.1 INTRODUCTION 192
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 192
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET 192
11.3 REVENUE ANALYSIS, 2021?2024 194
11.4 MARKET SHARE ANALYSIS, 2024 195
11.5 COMPANY VALUATION & FINANCIAL METRICS 197
11.5.1 FINANCIAL METRICS 197
11.5.2 COMPANY VALUATION 197
11.6 BRAND/PRODUCT COMPARISON 198
?
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 198
11.7.1 STARS 198
11.7.2 EMERGING LEADERS 199
11.7.3 PERVASIVE PLAYERS 199
11.7.4 PARTICIPANTS 199
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 200
11.7.5.1 Company footprint 200
11.7.5.2 Region footprint 200
11.7.5.3 Product footprint 201
11.7.5.4 Application footprint 202
11.7.5.5 End-user footprint 203
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES (2024) 203
11.8.1 PROGRESSIVE COMPANIES 203
11.8.2 RESPONSIVE COMPANIES 203
11.8.3 DYNAMIC COMPANIES 204
11.8.4 STARTING BLOCKS 204
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 205
11.8.5.1 Detailed list of key startups/SMEs 205
11.8.5.2 Competitive benchmarking of key startups/SMEs 206
11.9 COMPETITIVE SCENARIO 207
11.9.1 PRODUCT APPROVALS 207
11.9.2 DEALS 208
11.9.3 EXPANSIONS 209
12 COMPANY PROFILES 210
12.1 KEY PLAYERS 210
12.1.1 DANAHER CORPORATION 210
12.1.1.1 Business overview 210
12.1.1.2 Products offered 211
12.1.1.3 Recent developments 214
12.1.1.3.1 Deals 214
12.1.1.3.2 Expansions 215
12.1.1.4 MnM view 215
12.1.1.4.1 Key strengths 215
12.1.1.4.2 Strategic choices 215
12.1.1.4.3 Weaknesses & competitive threats 215
12.1.2 RAYBIOTECH, INC. 216
12.1.2.1 Business overview 216
12.1.2.2 Products offered 216
12.1.2.3 Recent developments 219
12.1.2.3.1 Deals 219
?
12.1.2.4 MnM view 219
12.1.2.4.1 Key strengths 219
12.1.2.4.2 Strategic choices 219
12.1.2.4.3 Weaknesses & competitive threats 219
12.1.3 MERCK & CO., INC. 220
12.1.3.1 Business overview 220
12.1.3.2 Products offered 221
12.1.3.3 Recent developments 223
12.1.3.3.1 Deals 223
12.1.3.4 MnM view 223
12.1.3.4.1 Key strengths 223
12.1.3.4.2 Strategic choices 224
12.1.3.4.3 Weaknesses & competitive threats 224
12.1.4 AMGEN INC. 225
12.1.4.1 Business overview 225
12.1.4.2 Products offered 226
12.1.4.3 Recent developments 226
12.1.4.3.1 Product approvals 226
12.1.4.3.2 Deals 227
12.1.4.4 MnM view 227
12.1.4.4.1 Key strengths 227
12.1.4.4.2 Strategic choices 227
12.1.4.4.3 Weaknesses & competitive threats 227
12.1.5 ELI LILLY AND COMPANY 228
12.1.5.1 Business overview 228
12.1.5.2 Products offered 229
12.1.5.3 Recent developments 230
12.1.5.3.1 Product approvals 230
12.1.5.3.2 Deals 230
12.1.5.4 MnM view 231
12.1.5.4.1 Key strengths 231
12.1.5.4.2 Strategic choices 231
12.1.5.4.3 Weaknesses & competitive threats 231
12.1.6 F. HOFFMANN-LA ROCHE LTD. 232
12.1.6.1 Business overview 232
12.1.6.2 Products offered 233
12.1.6.3 Recent developments 237
12.1.6.3.1 Product launches & approvals 237
12.1.6.4 Recent developments 238
12.1.6.4.1 Deals 238
?
12.1.7 NOVO NORDISK A/S 239
12.1.7.1 Business overview 239
12.1.7.2 Products offered 240
12.1.7.3 Recent developments 241
12.1.7.3.1 Deals 241
12.1.8 PFIZER INC. 242
12.1.8.1 Business overview 242
12.1.8.2 Products offered 243
12.1.8.3 Recent developments 244
12.1.8.3.1 Product approvals 244
12.1.8.3.2 Deals 244
12.1.9 THERMO FISHER SCIENTIFIC INC. 245
12.1.9.1 Business overview 245
12.1.9.2 Products offered 246
12.1.10 SANOFI 249
12.1.10.1 Business overview 249
12.1.10.2 Products offered 250
12.1.11 AGILENT TECHNOLOGIES, INC. 251
12.1.11.1 Business overview 251
12.1.11.2 Products offered 252
12.1.11.3 Recent developments 253
12.1.11.3.1 Deals 253
12.1.11.3.2 Expansions 254
12.1.12 TAKEDA PHARMACEUTICAL COMPANY LIMITED 255
12.1.12.1 Business overview 255
12.1.12.2 Products offered 256
12.1.12.3 Recent developments 256
12.1.12.3.1 Product approvals 256
12.1.13 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF) 257
12.1.13.1 Business overview 257
12.1.13.2 Products offered 258
12.1.13.3 Recent developments 259
12.1.13.3.1 Product launches & approvals 259
12.1.13.3.2 Deals 260
12.1.13.3.3 Expansions 260
12.1.14 BIOCON 261
12.1.14.1 Business overview 261
12.1.14.2 Products offered 262
12.1.14.3 Recent developments 263
12.1.14.3.1 Product approvals 263
12.1.14.3.2 Deals 263
?
12.2 OTHER PLAYERS 264
12.2.1 AMANO ENZYME INC. 264
12.2.2 ULTREZE ENZYMES 265
12.2.3 NEOGEN 267
12.2.4 BIOLAXI ENZYMES PVT. LTD. 268
12.2.5 GENSCRIPT 270
12.2.6 BIOSEUTICA 271
12.2.7 KERRY GROUP PLC 272
12.2.8 ASSOCIATED BRITISH FOODS PLC 273
12.2.9 K-GENIX GROUP 275
12.2.10 NAGASE & CO., LTD. 276
12.2.11 GRIFOLS, S.A 276
12.2.12 BASF 277
12.2.13 BIO-CAT 278
12.2.14 AMCO PROTEINS 279
12.2.15 PROTALIX BIOTHERAPEUTICS 280
13 RESEARCH METHODOLOGY 281
13.1 RESEARCH DATA 281
13.1.1 SECONDARY RESEARCH 281
13.1.1.1 Key secondary sources 282
13.1.1.2 Objectives of secondary research 282
13.1.1.3 Key data from secondary sources 283
13.1.2 PRIMARY RESEARCH 283
13.1.2.1 Key primary sources 284
13.1.2.2 Key objectives of primary research 284
13.1.2.3 Key industry insights 285
13.2 MARKET SIZE ESTIMATION APPROACH 286
13.2.1 COMPANY REVENUE ESTIMATION APPROACH 287
13.2.2 CUSTOMER-BASED MARKET ESTIMATION 288
13.2.3 TOP-DOWN APPROACH 289
13.3 MARKET FORECASTING APPROACH 291
13.4 DATA TRIANGULATION 292
13.5 MARKET SHARE ASSESSMENT 293
13.6 STUDY ASSUMPTIONS 293
13.7 RESEARCH LIMITATIONS 293
13.8 RISK ANALYSIS 294
?
14 APPENDIX 295
14.1 DISCUSSION GUIDE 295
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 299
14.3 CUSTOMIZATION OPTIONS 301
14.4 RELATED REPORTS 301
14.5 AUTHOR DETAILS 302

ページTOPに戻る

List of Tables/Graphs

TABLE 1 PROTEINS & PROTEIN CRYSTALS MARKET: INCLUSIONS & EXCLUSIONS 31
TABLE 2 UNMET NEEDS IN PROTEINS & PROTEIN CRYSTALS MARKET 50
TABLE 3 PROTEINS & PROTEIN CRYSTALS MARKET: PORTER’S FIVE FORCES 51
TABLE 4 AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY KEY PLAYER, 2024 (USD) 57
TABLE 5 AVERAGE SELLING PRICE TREND OF PROTEINS & PROTEIN CRYSTALS, BY REGION, 2022?2024 (USD) 59
TABLE 6 IMPORT DATA FOR HS CODE 3507, BY COUNTRY, 2021?2024 (USD THOUSAND) 61
TABLE 7 EXPORT DATA FOR HS CODE 3507, BY COUNTRY, 2021?2024 (USD THOUSAND) 62
TABLE 8 IMPORT DATA FOR HS CODE 293719, BY COUNTRY,
2021─2024 (USD THOUSAND) 63
TABLE 9 EXPORT DATA FOR HS CODE 293719, BY COUNTRY,
2021─2024 (USD THOUSAND) 64
TABLE 10 LIST OF MAJOR CONFERENCES & EVENTS IN PROTEINS & PROTEIN CRYSTALS MARKET, JANUARY 2025?DECEMBER 2026 65
TABLE 11 CASE STUDY: COMPUTATIONAL DESIGN OF HIGH-AFFINITY MINIBINDER PROTEINS FOR THERAPEUTIC TARGETS 68
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES 69
TABLE 13 CASE STUDY: ALPHAFOLD BY DEEPMIND 73
TABLE 14 KEY REGULATORY AGENCIES 76
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 19 MIDDLE EAST: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 20 AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 21 INDUSTRY STANDARDS FOR PROTEINS & PROTEIN CRYSTALS MARKET 81
TABLE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN PROTEINS & PROTEIN CRYSTALS MARKET (%) 83
TABLE 23 KEY BUYING CRITERIA FOR MAJOR END USERS IN PROTEINS & PROTEIN CRYSTALS MARKET 84
TABLE 24 PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 87
TABLE 25 ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 88
TABLE 26 ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION,
2023?2030 (USD BILLION) 88
TABLE 27 ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2023?2030 (USD BILLION) 89
TABLE 28 ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET FOR FOOD ENZYMES,
BY REGION, 2023?2030 (USD BILLION) 90
TABLE 29 THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 91
TABLE 30 THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION,
2023?2030 (USD BILLION) 91
TABLE 31 THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023?2030 (USD BILLION) 92
TABLE 32 THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR INSULIN, BY REGION, 2023?2030 (USD BILLION) 93
TABLE 33 THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR HORMONES,
BY REGION, 2023?2030 (USD BILLION) 94
TABLE 34 THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET FOR COAGULATION FACTORS, BY REGION, 2023?2030 (USD BILLION) 95
TABLE 35 STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 96
TABLE 36 STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION,
2023?2030 (USD BILLION) 96
TABLE 37 STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET FOR RESEARCH PROTEINS, BY REGION, 2023?2030 (USD BILLION) 97
TABLE 38 STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET FOR STRUCTURAL PROTEINS, BY REGION, 2023?2030 (USD BILLION) 98
TABLE 39 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 99
TABLE 40 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION,
2023?2030 (USD BILLION) 99
TABLE 41 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR INDUSTRIAL PROTEINS, BY REGION, 2023?2030 (USD BILLION) 100
TABLE 42 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR NUTRITIONAL PROTEINS, BY REGION, 2023?2030 (USD BILLION) 101
TABLE 43 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR ANALYTICAL PROTEINS, BY REGION, 2023?2030 (USD BILLION) 102
TABLE 44 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR COSMECEUTICAL PROTEINS, BY REGION, 2023?2030 (USD BILLION) 103
TABLE 45 SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET FOR FUNCTIONAL FOOD PROTEINS, BY REGION, 2023?2030 (USD BILLION) 104
TABLE 46 PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION,
2023?2030 (USD BILLION) 106
TABLE 47 PROTEINS & PROTEIN CRYSTALS APPLICATIONS MARKET, BY REGION,
2023?2030 (USD BILLION) 106
TABLE 48 PROTEINS & PROTEIN CRYSTALS MARKET FOR HEALTHCARE, BY REGION,
2023?2030 (USD BILLION) 107
TABLE 49 PROTEINS & PROTEIN CRYSTALS MARKET FOR TISSUE ENGINEERING, BY REGION, 2023?2030 (USD BILLION) 108
TABLE 50 PROTEINS & PROTEIN CRYSTALS MARKET FOR AGRICULTURE & ANIMAL NUTRITION, BY REGION, 2023?2030 (USD BILLION) 109
TABLE 51 PROTEINS & PROTEIN CRYSTALS MARKET FOR INDUSTRIAL PROCESSING,
BY REGION, 2023?2030 (USD BILLION) 110
TABLE 52 PROTEINS & PROTEIN CRYSTALS MARKET FOR BIOENERGY & ENVIRONMENTAL, BY REGION, 2023?2030 (USD BILLION) 111
TABLE 53 PROTEINS & PROTEIN CRYSTALS MARKET FOR COSMECEUTICAL & NUTRACEUTICALS, BY REGION, 2023?2030 (USD BILLION) 112
TABLE 54 PROTEINS & PROTEIN CRYSTALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023?2030 (USD BILLION) 113
TABLE 55 PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER,
2023?2030 (USD BILLION) 115
TABLE 56 PROTEINS & PROTEIN CRYSTALS MARKET FOR PHARMA INDUSTRY, BY TYPE, 2023?2030 (USD BILLION) 116
TABLE 57 PROTEINS & PROTEIN CRYSTALS MARKET FOR PHARMA INDUSTRY, BY REGION, 2023?2030 (USD BILLION) 116
TABLE 58 PHARMA INDUSTRY MARKET FOR DRUG DEVELOPMENT, BY REGION,
2023?2030 (USD BILLION) 117
TABLE 59 PHARMA INDUSTRY MARKET FOR FORMULATION/MANUFACTURING, BY REGION, 2023?2030 (USD BILLION) 118
TABLE 60 PHARMA INDUSTRY MARKET FOR STORAGE/INVENTORY MANAGEMENT,
BY REGION, 2023?2030 (USD BILLION) 119
TABLE 61 PROTEINS & PROTEIN CRYSTALS MARKET FOR BIOTECHNOLOGY INDUSTRY,
BY TYPE, 2023?2030 (USD BILLION) 119
TABLE 62 PROTEINS & PROTEIN CRYSTALS MARKET FOR BIOTECHNOLOGY INDUSTRY,
BY REGION, 2023?2030 (USD BILLION) 120
TABLE 63 BIOTECHNOLOGY INDUSTRY MARKET FOR DRUG DEVELOPMENT, BY REGION, 2023?2030 (USD BILLION) 121
TABLE 64 BIOTECHNOLOGY INDUSTRY MARKET FOR FORMULATION/MANUFACTURING,
BY REGION, 2023?2030 (USD BILLION) 122
TABLE 65 BIOTECHNOLOGY INDUSTRY MARKET FOR STORAGE/INVENTORY MANAGEMNET, BY REGION, 2023?2030 (USD BILLION) 123
TABLE 66 PROTEINS & PROTEIN CRYSTALS MARKET FOR RESEARCH, ACADEMIA, AND CROS, BY TYPE, 2023?2030 (USD BILLION) 124
TABLE 67 PROTEINS & PROTEIN CRYSTALS MARKET FOR RESEARCH, ACADEMIA, AND CROS, BY REGION, 2023?2030 (USD BILLION) 124
TABLE 68 RESEARCH, ACADEMIA, AND CROS MARKET FOR DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2023?2030 (USD BILLION) 125
TABLE 69 RESEARCH, ACADEMIA, AND CROS MARKET FOR LIFE SCIENCE RESEARCH,
BY REGION, 2023?2030 (USD BILLION) 126
TABLE 70 PROTEINS & PROTEIN CRYSTALS MARKET FOR FOOD & BEVERAGE INDUSTRY,
BY REGION, 2023?2030 (USD BILLION) 126
TABLE 71 PROTEINS & PROTEIN CRYSTALS MARKET FOR OTHER END USERS, BY REGION, 2023?2030 (USD BILLION) 127
TABLE 72 PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023?2030 (USD BILLION) 129
TABLE 73 NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY,
2023?2030 (USD BILLION) 130
TABLE 74 NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 131
TABLE 75 NORTH AMERICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 131
TABLE 76 NORTH AMERICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 131
TABLE 77 NORTH AMERICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 132
TABLE 78 NORTH AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 132
TABLE 79 NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023?2030 (USD BILLION) 133
TABLE 80 NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023?2030 (USD BILLION) 133
TABLE 81 US: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 134
TABLE 82 US: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 135
TABLE 83 US: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 135
TABLE 84 US: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 135
TABLE 85 US: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 136
TABLE 86 CANADA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 137
TABLE 87 CANADA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 137
TABLE 88 CANADA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 137
TABLE 89 CANADA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 138
TABLE 90 CANADA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 138
TABLE 91 EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY,
2023?2030 (USD BILLION) 139
TABLE 92 EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 139
TABLE 93 EUROPE: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE
2023?2030 (USD BILLION) 139
TABLE 94 EUROPE: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 140
TABLE 95 EUROPE: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE
2023?2030 (USD BILLION) 140
TABLE 96 EUROPE: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 140
TABLE 97 EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION,
2023?2030 (USD BILLION) 141
TABLE 98 EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER,
2023?2030 (USD BILLION) 141
TABLE 99 GERMANY: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 142
TABLE 100 GERMANY: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 142
TABLE 101 GERMANY: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 143
TABLE 102 GERMANY: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 143
TABLE 103 GERMANY: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 143
TABLE 104 UK: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 144
TABLE 105 UK: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 145
TABLE 106 UK: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 145
TABLE 107 UK: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 145
TABLE 108 UK: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 146
TABLE 109 FRANCE: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 147
TABLE 110 FRANCE: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 147
TABLE 111 FRANCE: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 148
TABLE 112 FRANCE: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 148
TABLE 113 FRANCE: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 148
TABLE 114 ITALY: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 149
TABLE 115 ITALY: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 150
TABLE 116 ITALY: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 150
TABLE 117 ITALY: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 150
TABLE 118 ITALY: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 151
TABLE 119 SPAIN: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 152
TABLE 120 SPAIN: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 152
TABLE 121 SPAIN: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 152
TABLE 122 SPAIN: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 153
TABLE 123 SPAIN: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 153
TABLE 124 REST OF EUROPE: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 154
TABLE 125 REST OF EUROPE: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 154
TABLE 126 REST OF EUROPE: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 154
TABLE 127 REST OF EUROPE: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 155
TABLE 128 REST OF EUROPE: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 155
TABLE 129 ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY,
2023?2030 (USD BILLION) 156
TABLE 130 ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY,
2023?2030 (USD BILLION) 157
TABLE 131 ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 157
TABLE 132 ASIA PACIFIC: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 157
TABLE 133 ASIA PACIFIC: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 158
TABLE 134 ASIA PACIFIC: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 158
TABLE 135 ASIA PACIFIC: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 158
TABLE 136 ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION,
2023?2030 (USD BILLION) 159
TABLE 137 ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER,
2023?2030 (USD BILLION) 159
TABLE 138 CHINA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 160
TABLE 139 CHINA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 160
TABLE 140 CHINA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 160
TABLE 141 CHINA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 161
TABLE 142 CHINA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 161
TABLE 143 JAPAN: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 162
TABLE 144 JAPAN: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 163
TABLE 145 JAPAN: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 163
TABLE 146 JAPAN: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 163
TABLE 147 JAPAN: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 164
TABLE 148 INDIA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 165
TABLE 149 INDIA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 165
TABLE 150 INDIA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 166
TABLE 151 INDIA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 166
TABLE 152 INDIA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 166
TABLE 153 AUSTRALIA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 167
TABLE 154 AUSTRALIA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 168
TABLE 155 AUSTRALIA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 168
TABLE 156 AUSTRALIA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 168
TABLE 157 AUSTRALIA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 169
TABLE 158 SOUTH KOREA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 170
TABLE 159 SOUTH KOREA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 170
TABLE 160 SOUTH KOREA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 170
TABLE 161 SOUTH KOREA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 171
TABLE 162 SOUTH KOREA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 171
TABLE 163 REST OF ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 172
TABLE 164 REST OF ASIA PACIFIC: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 172
TABLE 165 REST OF ASIA PACIFIC: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 172
TABLE 166 REST OF ASIA PACIFIC: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 173
TABLE 167 REST OF ASIA PACIFIC: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD MILLION) 173
TABLE 168 LATIN AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY COUNTRY,
2023?2030 (USD BILLION) 174
TABLE 169 LATIN AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 174
TABLE 170 LATIN AMERICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 175
TABLE 171 LATIN AMERICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 175
TABLE 172 LATIN AMERICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 175
TABLE 173 LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 176
TABLE 174 LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET,
BY APPLICATION, 2023?2030 (USD BILLION) 176
TABLE 175 LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023?2030 (USD BILLION) 177
TABLE 176 BRAZIL: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 178
TABLE 177 BRAZIL: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 178
TABLE 178 BRAZIL: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 178
TABLE 179 BRAZIL: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 179
TABLE 180 BRAZIL: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 179
TABLE 181 MEXICO: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE,
2023?2030 (USD BILLION) 180
TABLE 182 MEXICO: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 180
TABLE 183 MEXICO: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 181
TABLE 184 MEXICO: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 181
TABLE 185 MEXICO: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE,
2023?2030 (USD BILLION) 181
TABLE 186 REST OF LATIN AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 182
TABLE 187 REST OF LATIN AMERICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 182
TABLE 188 REST OF LATIN AMERICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 183
TABLE 189 REST OF LATIN AMERICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 183
TABLE 190 REST OF LATIN AMERICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 183
TABLE 191 MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY REGION, 2023?2030 (USD BILLION) 184
TABLE 192 MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 185
TABLE 193 MIDDLE EAST & AFRICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 185
TABLE 194 MIDDLE EAST & AFRICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 185
TABLE 195 MIDDLE EAST & AFRICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 186
TABLE 196 MIDDLE EAST & AFRICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 186
TABLE 197 MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY APPLICATION, 2023?2030 (USD BILLION) 187
TABLE 198 MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET, BY END USER, 2023?2030 (USD BILLION) 187
TABLE 199 GCC COUNTRIES: PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT TYPE, 2023?2030 (USD BILLION) 188
TABLE 200 GCC COUNTRIES: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 188
TABLE 201 GCC COUNTRIES: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 189
TABLE 202 GCC COUNTRIES: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET,
BY TYPE, 2023?2030 (USD BILLION) 189
TABLE 203 GCC COUNTRIES: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 189
TABLE 204 REST OF MIDDLE EAST & AFRICA: PROTEINS & PROTEIN CRYSTALS MARKET,
BY PRODUCT TYPE, 2023?2030 (USD BILLION) 190
TABLE 205 REST OF MIDDLE EAST & AFRICA: ENZYMATIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 190
TABLE 206 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 191
TABLE 207 REST OF MIDDLE EAST & AFRICA: STRUCTURAL PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 191
TABLE 208 REST OF MIDDLE EAST & AFRICA: SPECIALTY PROTEINS & PROTEIN CRYSTALS MARKET, BY TYPE, 2023?2030 (USD BILLION) 191
TABLE 209 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN PROTEINS & PROTEIN CRYSTALS MARKET 192
TABLE 210 PROTEINS & PROTEIN CRYSTALS MARKET: DEGREE OF COMPETITION 195
TABLE 211 PROTEINS & PROTEIN CRYSTALS MARKET: REGION FOOTPRINT 200
TABLE 212 PROTEINS & PROTEIN CRYSTALS MARKET: PRODUCT FOOTPRINT 201
TABLE 213 PROTEINS & PROTEIN CRYSTALS MARKET: APPLICATION FOOTPRINT 202
TABLE 214 PROTEINS & PROTEIN CRYSTALS MARKET: END-USER FOOTPRINT 203
TABLE 215 PROTEINS & PROTEIN CRYSTALS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 205
TABLE 216 PROTEINS & PROTEIN CRYSTALS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY REGION 206
TABLE 217 PROTEINS & PROTEIN CRYSTALS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT TYPE 206
TABLE 218 PROTEINS & PROTEIN CRYSTALS MARKET: PRODUCT APPROVALS, JANUARY 2022?DECEMBER 2025 207
TABLE 219 PROTEINS & PROTEIN CRYSTALS MARKET: DEALS,
JANUARY 2022?DECEMBER 2025 208
TABLE 220 PROTEINS & PROTEIN CRYSTALS MARKET: DEALS,
JANUARY 2022?DECEMBER 2025 209
TABLE 221 DANAHER CORPORATION: COMPANY OVERVIEW 210
TABLE 222 DANAHER CORPORATION: PRODUCTS OFFERED 211
TABLE 223 DANAHER CORPORATION: DEALS, JANUARY 2022?DECEMBER 2025 214
TABLE 224 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022?DECEMBER 2025 215
TABLE 225 RAYBIOTECH, INC.: COMPANY OVERVIEW 216
TABLE 226 RAYBIOTECH, INC.: PRODUCTS OFFERED 216
TABLE 227 RAYBIOTECH, INC.: DEALS, JANUARY 2022?DECEMBER 2025 219
TABLE 228 MERCK & CO., INC.: COMPANY OVERVIEW 220
TABLE 229 MERCK & CO., INC.: PRODUCTS OFFERED 221
TABLE 230 MERCK & CO., INC.: DEALS, JANUARY 2022?DECEMBER 2025 223
TABLE 231 AMGEN INC.: COMPANY OVERVIEW 225
TABLE 232 AMGEN INC.: PRODUCTS OFFERED 226
TABLE 233 AMGEN INC.: PRODUCT APPROVALS, JANUARY 2022?DECEMBER 2025 226
TABLE 234 AMGEN INC.: DEALS, JANUARY 2022?DECEMBER 2025 227
TABLE 235 ELI LILLY AND COMPANY: COMPANY OVERVIEW 228
TABLE 236 ELI LILLY AND COMPANY: PRODUCTS OFFERED 229
TABLE 237 ELI LILLY AND COMPANY: PRODUCT APPROVALS,
JANUARY 2022?DECEMBER 2025 230
TABLE 238 ELI LILLY AND COMPANY: DEALS, JANUARY 2022?DECEMBER 2025 230
TABLE 239 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 232
TABLE 240 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 233
TABLE 241 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?DECEMBER 2025 237
TABLE 242 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022?DECEMBER 2025 238
TABLE 243 NOVO NORDISK A/S: COMPANY OVERVIEW 239
TABLE 244 NOVO NORDISK A/S: PRODUCTS OFFERED 240
TABLE 245 NOVO NORDISK A/S: DEALS, JANUARY 2022?DECEMBER 2025 241
TABLE 246 PFIZER INC.: COMPANY OVERVIEW 242
TABLE 247 PFIZER INC.: PRODUCTS OFFERED 243
TABLE 248 PFIZER INC.: PRODUCT APPROVALS, JANUARY 2022?DECEMBER 2025 244
TABLE 249 PFIZER INC.: DEALS, JANUARY 2022?DECEMBER 2025 244
TABLE 250 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 245
TABLE 251 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 246
TABLE 252 SANOFI: COMPANY OVERVIEW 249
TABLE 253 SANOFI: PRODUCTS OFFERED 250
TABLE 254 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 251
TABLE 255 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 252
TABLE 256 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022?DECEMBER 2025 253
TABLE 257 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022?DECEMBER 2025 254
TABLE 258 TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY OVERVIEW 255
TABLE 259 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED 256
TABLE 260 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT APPROVALS, JANUARY 2022?DECEMBER 2025 256
TABLE 261 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): COMPANY OVERVIEW 257
TABLE 262 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): PRODUCTS OFFERED 258
TABLE 263 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?DECEMBER 2025 259
TABLE 264 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): DEALS,
JANUARY 2022?DECEMBER 2025 260
TABLE 265 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): EXPANSIONS,
JANUARY 2022?DECEMBER 2025 260
TABLE 266 BIOCON: COMPANY OVERVIEW 261
TABLE 267 BIOCON: PRODUCTS OFFERED 262
TABLE 268 BIOCON: PRODUCT APPROVALS, JANUARY 2022?DECEMBER 2025 263
TABLE 269 BIOCON: DEALS, JANUARY 2022?DECEMBER 2025 263
TABLE 270 AMANO ENZYME INC.: COMPANY OVERVIEW 264
TABLE 271 ULTREZE ENZYMES: COMPANY OVERVIEW 265
TABLE 272 NEOGEN: COMPANY OVERVIEW 267
TABLE 273 BIOLAXI ENZYMES PVT. LTD.: COMPANY OVERVIEW 268
TABLE 274 GENSCRIPT: COMPANY OVERVIEW 270
TABLE 275 BIOSEUTICA: COMPANY OVERVIEW 271
TABLE 276 KERRY GROUP PLC: COMPANY OVERVIEW 272
TABLE 277 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW 273
TABLE 278 K-GENIX GROUP: COMPANY OVERVIEW 275
TABLE 279 NAGASE & CO., LTD.: COMPANY OVERVIEW 276
TABLE 280 GRIFOLS, S.A : COMPANY OVERVIEW 276
TABLE 281 BASF: COMPANY OVERVIEW 277
TABLE 282 BIO-CAT: COMPANY OVERVIEW 278
TABLE 283 AMCO PROTEINS: COMPANY OVERVIEW 279
TABLE 284 PROTALIX BIOTHERAPEUTICS: COMPANY OVERVIEW 280
TABLE 285 PROTEINS & PROTEIN CRYSTALS MARKET: STUDY ASSUMPTIONS 293
TABLE 286 PROTEINS & PROTEIN CRYSTALS MARKET: RISK ANALYSIS 294FIGURE 1 PROTEINS & PROTEIN CRYSTALS MARKET SEGMENTATION & REGIONAL SCOPE 30
FIGURE 2 PROTEINS & PROTEIN CRYSTALS MARKET: YEARS CONSIDERED 31
FIGURE 3 MARKET SCENARIO FOR PROTEINS & PROTEIN CRYSTALS MARKET 33
FIGURE 4 GLOBAL PROTEINS & PROTEIN CRYSTALS MARKET, BY PRODUCT,
2024?2030 (USD BILLION) 33
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2021?2024 34
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PROTEINS & PROTEIN CRYSTALS MARKET 35
FIGURE 7 HIGH-GROWTH SEGMENTS IN PROTEINS & PROTEIN CRYSTALS MARKET,
2025?2030 36
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 37
FIGURE 9 RAPID EXPANSION OF BIOLOGICS AND RECOMBINANT PROTEIN THERAPEUTICS TO PROPEL MARKET GROWTH 38
FIGURE 10 GLOBAL FORMULATIONS/END PRODUCTS, PROTEINS & PROTEIN CRYSTALS & CRYSTAALLOGRAPHY MARKET, BY PRODUCT SEGMENT,
2025-2030 (USD BILLION) 39
FIGURE 11 US AND PHARMA INDUSTRY COMMANDED LARGEST MARKET SHARE IN 2025 40
FIGURE 12 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 41
FIGURE 13 PROTEINS & PROTEIN CRYSTALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
FIGURE 14 PROTEINS & PROTEIN CRYSTALS MARKET: PORTER’S FIVE FORCES ANALYSIS 51
FIGURE 15 PROTEINS & PROTEIN CRYSTALS MARKET: SUPPLY CHAIN ANALYSIS 55
FIGURE 16 PROTEINS & PROTEIN CRYSTALS MARKET: VALUE CHAIN ANALYSIS 56
FIGURE 17 PROTEINS & PROTEIN CRYSTALS MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 18 AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY PRODUCT,
2024 (USD) 58
FIGURE 19 AVERAGE SELLING PRICE OF PROTEINS & PROTEIN CRYSTALS, BY REGION,
2024 (USD THOUSAND) 59
FIGURE 20 PROTEINS & PROTEIN CRYSTALS MARKET: IMPORT DATA FOR HS CODE 3507, 2021?2024 61
FIGURE 21 PROTEINS & PROTEIN CRYSTALS MARKET: EXPORT DATA FOR HS CODE 3507, 2021?2024 62
FIGURE 22 PROTEINS & PROTEIN CRYSTALS MARKET: IMPORT SCENARIO FOR HS CODE 293719, 2021?2024 63
FIGURE 23 PROTEINS & PROTEIN CRYSTALS MARKET: EXPORT SCENARIO FOR HS CODE 293719, BY COUNTRY, 2021?2024 (USD THOUSAND) 64
FIGURE 24 PROTEINS & PROTEIN CRYSTALS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 66
FIGURE 25 FUNDING AND NUMBER OF DEALS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2019?2023 (USD MILLION) 67
FIGURE 26 NUMBER OF INVESTOR DEALS IN PROTEINS & PROTEIN CRYSTALS MARKET,
BY KEY PLAYER, 2019?2023 67
FIGURE 27 VALUE OF INVESTOR DEALS IN PROTEINS & PROTEIN CRYSTALS MARKET, BY KEY PLAYER, 2019?2023 (USD MILLION) 68
FIGURE 28 PATENT ANALYSIS FOR PROTEINS & PROTEIN CRYSTALS MARKET
(JANUARY 2014?NOVEMBER 2025) 72
FIGURE 29 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN PROTEINS & PROTEIN CRYSTALS MARKET 83
FIGURE 30 KEY BUYING CRITERIA FOR MAJOR END USERS IN PROTEINS & PROTEIN CRYSTALS MARKET 84
FIGURE 31 NORTH AMERICA: PROTEINS & PROTEIN CRYSTALS MARKET SNAPSHOT 130
FIGURE 32 ASIA PACIFIC: PROTEINS & PROTEIN CRYSTALS MARKET SNAPSHOT 156
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET, 2021?2024 (USD MILLION) 194
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET (2024) 195
FIGURE 35 RANKING OF KEY PLAYERS IN PROTEINS & PROTEIN CRYSTALS MARKET (2024) 196
FIGURE 36 EV/EBITDA OF KEY VENDORS 197
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 197
FIGURE 38 PROTEINS & PROTEIN CRYSTALS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 198
FIGURE 39 PROTEINS & PROTEIN CRYSTALS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 199
FIGURE 40 PROTEINS & PROTEIN CRYSTALS MARKET: COMPANY FOOTPRINT 200
FIGURE 41 PROTEINS & PROTEIN CRYSTALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 204
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT 211
FIGURE 43 MERCK & CO., INC.: COMPANY SNAPSHOT 221
FIGURE 44 AMGEN INC.: COMPANY SNAPSHOT 225
FIGURE 45 ELI LILLY AND COMPANY: COMPANY SNAPSHOT 228
FIGURE 46 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 232
FIGURE 47 NOVO NORDISK A/S: COMPANY SNAPSHOT 240
FIGURE 48 PFIZER INC.: COMPANY SNAPSHOT 243
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 245
FIGURE 50 SANOFI: COMPANY SNAPSHOT 249
FIGURE 51 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 252
FIGURE 52 TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT 255
FIGURE 53 INTERNATIONAL FLAVOURS & FRAGRANCES INC. (IFF): COMPANY SNAPSHOT 258
FIGURE 54 BIOCON: COMPANY SNAPSHOT 262
FIGURE 55 PROTEINS & PROTEIN CRYSTALS MARKET: RESEARCH DESIGN 281
FIGURE 56 PROTEINS & PROTEIN CRYSTALS MARKET: KEY SECONDARY SOURCES 282
FIGURE 57 PROTEINS & PROTEIN CRYSTALS MARKET: KEY DATA FROM SECONDARY SOURCES 283
FIGURE 58 PROTEINS & PROTEIN CRYSTALS MARKET: PRIMARY SOURCES
(SUPPLY AND DEMAND SIDES) 284
FIGURE 59 PROTEINS & PROTEIN CRYSTALS MARKET: KEY INDUSTRY INSIGHTS 285
FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 285
FIGURE 61 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 286
FIGURE 62 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 287
FIGURE 63 PROTEINS & PROTEIN CRYSTALS MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 288
FIGURE 64 PROTEINS & PROTEIN CRYSTALS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 289
FIGURE 65 PROTEINS & PROTEIN CRYSTALS MARKET: TOP-DOWN APPROACH 289
FIGURE 66 GLOBAL PROTEINS & PROTEIN CRYSTALS MARKET GROWTH PROJECTIONS 291
FIGURE 67 PROTEINS & PROTEIN CRYSTALS MARKET: DATA TRIANGULATION METHODOLOGY 292